Trade IMMP anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Immutep Limited American Depositary Shares (IMMP) is trading at US$0.39, up 1.63% today as of Aug 28, 10:20 EDT. The company has a market capitalisation of US$56.9M. Over the past 52 weeks, IMMP has traded between US$0.29 and US$3.53. On Syfe you can trade IMMP with $0 commission and add it to your watchlist.
| Previous close | US$0.38 |
|---|---|
| Market cap | US$56.9M |
| 52-week range | US$0.29 – US$3.53 |
| Volume | 129.38K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Immutep Limited American Depositary Shares
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alfa (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731). The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.
Year: 1988
Immutep Granted New US Patent for Cancer Treatment Methods
Jul 14, 12:42 PM · MT Newswires
Immutep Shares Rise After Maxim Group Upgrade
Jun 17, 6:56 PM · MT Newswires
--Maxim Group Upgrades Immutep to Buy From Hold, $1.50 Price Target
Jun 17, 12:30 PM · MT Newswires
Sector Update: Health Care Stocks Decline Late Afternoon
Apr 15, 7:56 PM · MT Newswires
Sector Update: Health Care Stocks Lower in Afternoon Trading
Apr 15, 5:55 PM · MT Newswires
Stay on top of IMMP
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
